Article Notes
- Do not routinely reverse muscle relaxants (65% and 82% respectively US & EU).
- Do not have access to quantitative NMBD monitors (77% and 30%).
- Do not ever use neuromuscular monitors (9% and 19%).
This is a very significant and large study, and should give us pause to ponder the consequences of invasive airway management and surgery requiring muscle relaxation. It is also important to note that qualitative neuromuscular monitoring (as opposed to quantitative) appears to offer no risk reduction, consistent with other research in this area.
Nonetheless, the retrospective nature of this study means these relationships should not necessarily be viewed as causal. This is not a study of an intervention per se, but the association between certain perioperative characteristics that may be unavoidable (e.g. using muscle relaxants).
An important paper for any concerned anaesthetist or anesthesiologist to read in full.
This very large cohort study demonstrated an association between use of intermediate-duration NMBD and risk of postoperative desaturation and reintubation requiring ICU admission, and a similar association with these outcomes and neostigmine reversal.
Qualitative neuromuscular monitoring did not reduce this risk.
Study population was all patients at Massachusetts General Hospital undergoing general anaesthesia including a muscle relaxant over a 4 year period, and who were extubated at the end of the procedure.
Observation of pharyngeal function in 14 awake volunteers demonstrated pharyngeal dysfunction and increased aspiration risk at TOF ratios < 0.90.
“Partial neuromuscular paralysis caused by atracurium is associated with a four- to fivefold increase in the incidence of misdirected swallowing. … The majority of misdirected swallows resulted in penetration of bolus to the larynx.”
(Sundman in a 2000 follow-up study: The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium.)
Murphy et al. showed in this randomised, non-blinded trial that patients monitored with quantitative acceleromyography before extubation experienced less PORC, less desaturation below 90% (0% versus 21%) and less airway obstruction (0% versus 11%) during transport to the PACU.
Once in the PACU these patients also experienced less frequent, shorter duration and less severe hypoxic events.
This small (N=64) post-operative audit of children receiving muscle relaxants in an Australian tertiary paediatric hospital identified a 28% incidence of post-operative residual paralysis, measured immediately before extubation.
Worryingly, the incidence of residual paralysis was even higher in the subgroup reversed with neostigmine (38%), which the authors attribute to anaesthetists not waiting long enough after administration.
Severe residual paralysis (TOFR < 0.7) was observed in 7% of cases.
Only 23% of anaesthetists used intra-operative neuromuscular monitoring.
This is a great review to start with, providing a good overview of many of the myths regarding the use of neuromuscular blocking drugs that are still widely believed and practised by the global anaesthesia community.
All five of Fink & Hollman's 'myths' still hold today after reviewing the latest research in these areas.
This 2010 survey found that a significant proportion of both American anesthesiologists and European anaesthetists:
Debaene et al. investigated residual paralysis in the PACU after a single intubating dose of intermediate NMBD in the absence of reversal.
They identified PORC (Post-Operative Residual Curarization = TOFR <0.9) in 45% of patients, with 'time since NMBD' ranging from 30 to 400 minutes.
In a subgroup of patients 2 hours after a single NMBD dose there was still a 37% incidence of PORC.
Additionally there was very wide inter-patient variability, with PORC persisting more than 6 hours in three patients, and several patients with TOFR of only 0.2 after 2 hours.